Palantir Faces Scrutiny Over Alleged Contract Breach With NHS: Report – Palantir Technologies (NYSE:PLTR)

The UK’s NHS is investigating whether Palantir Technologies breached contract terms after launching an influencer marketing campaign without prior consent. Critics have raised concerns about Palantir’s handling of private medical data and a lack of transparency. Palantir, which won a contract with Accenture to build a £330m ($419m) patient data platform for the NHS, branded its campaign an “exploratory project” that never came to fruition.